Neuropathic Pain Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anticonvulsants
1.2.3 Antidepressants
1.2.4 NSAIDs
1.2.5 Opioids
1.2.6 Steroids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Neuropathic Pain Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diabetic Neuropathy
1.3.3 Chemotherapy-Induced Neuropathy Pain
1.3.4 Postherpetic Neuralgia
1.3.5 Spinal Cord Injury
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuropathic Pain Therapeutics Market Perspective (2017-2028)
2.2 Neuropathic Pain Therapeutics Growth Trends by Region
2.2.1 Neuropathic Pain Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neuropathic Pain Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Neuropathic Pain Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Neuropathic Pain Therapeutics Market Dynamics
2.3.1 Neuropathic Pain Therapeutics Industry Trends
2.3.2 Neuropathic Pain Therapeutics Market Drivers
2.3.3 Neuropathic Pain Therapeutics Market Challenges
2.3.4 Neuropathic Pain Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Pain Therapeutics Players by Revenue
3.1.1 Global Top Neuropathic Pain Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Neuropathic Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuropathic Pain Therapeutics Revenue
3.4 Global Neuropathic Pain Therapeutics Market Concentration Ratio
3.4.1 Global Neuropathic Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Therapeutics Revenue in 2021
3.5 Neuropathic Pain Therapeutics Key Players Head office and Area Served
3.6 Key Players Neuropathic Pain Therapeutics Product Solution and Service
3.7 Date of Enter into Neuropathic Pain Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Pain Therapeutics Breakdown Data by Type
4.1 Global Neuropathic Pain Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2023-2028)
5 Neuropathic Pain Therapeutics Breakdown Data by Application
5.1 Global Neuropathic Pain Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neuropathic Pain Therapeutics Market Size (2017-2028)
6.2 North America Neuropathic Pain Therapeutics Market Size by Type
6.2.1 North America Neuropathic Pain Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Neuropathic Pain Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Neuropathic Pain Therapeutics Market Share by Type (2017-2028)
6.3 North America Neuropathic Pain Therapeutics Market Size by Application
6.3.1 North America Neuropathic Pain Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Neuropathic Pain Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Neuropathic Pain Therapeutics Market Share by Application (2017-2028)
6.4 North America Neuropathic Pain Therapeutics Market Size by Country
6.4.1 North America Neuropathic Pain Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Neuropathic Pain Therapeutics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neuropathic Pain Therapeutics Market Size (2017-2028)
7.2 Europe Neuropathic Pain Therapeutics Market Size by Type
7.2.1 Europe Neuropathic Pain Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Neuropathic Pain Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Neuropathic Pain Therapeutics Market Share by Type (2017-2028)
7.3 Europe Neuropathic Pain Therapeutics Market Size by Application
7.3.1 Europe Neuropathic Pain Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Neuropathic Pain Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Neuropathic Pain Therapeutics Market Share by Application (2017-2028)
7.4 Europe Neuropathic Pain Therapeutics Market Size by Country
7.4.1 Europe Neuropathic Pain Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Neuropathic Pain Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type
8.2.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neuropathic Pain Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application
8.3.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neuropathic Pain Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region
8.4.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuropathic Pain Therapeutics Market Size (2017-2028)
9.2 Latin America Neuropathic Pain Therapeutics Market Size by Type
9.2.1 Latin America Neuropathic Pain Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Neuropathic Pain Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Neuropathic Pain Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Neuropathic Pain Therapeutics Market Size by Application
9.3.1 Latin America Neuropathic Pain Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Neuropathic Pain Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Neuropathic Pain Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Neuropathic Pain Therapeutics Market Size by Country
9.4.1 Latin America Neuropathic Pain Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Neuropathic Pain Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type
10.2.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neuropathic Pain Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application
10.3.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neuropathic Pain Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country
10.4.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathic Pain Therapeutics Introduction
11.1.4 Pfizer Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Neuropathic Pain Therapeutics Introduction
11.2.4 Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.2.5 Novartis AG Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neuropathic Pain Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Introduction
11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.5.5 Eli Lilly and Company Recent Developments
11.6 Mallinckrodt Pharmaceuticals
11.6.1 Mallinckrodt Pharmaceuticals Company Details
11.6.2 Mallinckrodt Pharmaceuticals Business Overview
11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Introduction
11.6.4 Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.6.5 Mallinckrodt Pharmaceuticals Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Introduction
11.7.4 Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.7.5 Johnson & Johnson Recent Developments
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Neuropathic Pain Therapeutics Introduction
11.8.4 Abbott Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.8.5 Abbott Recent Developments
11.9 Endo Pharmaceuticals, Inc.
11.9.1 Endo Pharmaceuticals, Inc. Company Details
11.9.2 Endo Pharmaceuticals, Inc. Business Overview
11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Introduction
11.9.4 Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.9.5 Endo Pharmaceuticals, Inc. Recent Developments
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Details
11.10.2 Teva Pharmaceutical Industries Limited Business Overview
11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Introduction
11.10.4 Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.10.5 Teva Pharmaceutical Industries Limited Recent Developments
11.11 Merck & Co
11.11.1 Merck & Co Company Details
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Neuropathic Pain Therapeutics Introduction
11.11.4 Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2017-2022)
11.11.5 Merck & Co Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Antidepressants
Table 4. Key Players of NSAIDs
Table 5. Key Players of Opioids
Table 6. Key Players of Steroids
Table 7. Key Players of Others
Table 8. Global Neuropathic Pain Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Neuropathic Pain Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Neuropathic Pain Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Neuropathic Pain Therapeutics Market Share by Region (2017-2022)
Table 12. Global Neuropathic Pain Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Neuropathic Pain Therapeutics Market Share by Region (2023-2028)
Table 14. Neuropathic Pain Therapeutics Market Trends
Table 15. Neuropathic Pain Therapeutics Market Drivers
Table 16. Neuropathic Pain Therapeutics Market Challenges
Table 17. Neuropathic Pain Therapeutics Market Restraints
Table 18. Global Neuropathic Pain Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Neuropathic Pain Therapeutics Revenue Share by Players (2017-2022)
Table 20. Global Top Neuropathic Pain Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Therapeutics as of 2021)
Table 21. Ranking of Global Top Neuropathic Pain Therapeutics Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Neuropathic Pain Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neuropathic Pain Therapeutics Product Solution and Service
Table 25. Date of Enter into Neuropathic Pain Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neuropathic Pain Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2017-2022)
Table 29. Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2023-2028)
Table 31. Global Neuropathic Pain Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Neuropathic Pain Therapeutics Revenue Share by Application (2017-2022)
Table 33. Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Neuropathic Pain Therapeutics Revenue Share by Application (2023-2028)
Table 35. North America Neuropathic Pain Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Neuropathic Pain Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Neuropathic Pain Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Neuropathic Pain Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Neuropathic Pain Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Neuropathic Pain Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Neuropathic Pain Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Neuropathic Pain Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Neuropathic Pain Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Neuropathic Pain Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Neuropathic Pain Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Neuropathic Pain Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Neuropathic Pain Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Neuropathic Pain Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Neuropathic Pain Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Neuropathic Pain Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Neuropathic Pain Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Neuropathic Pain Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Neuropathic Pain Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Neuropathic Pain Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Neuropathic Pain Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Neuropathic Pain Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Neuropathic Pain Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Neuropathic Pain Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Neuropathic Pain Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Neuropathic Pain Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Neuropathic Pain Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Neuropathic Pain Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Neuropathic Pain Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Neuropathic Pain Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Neuropathic Pain Therapeutics Product
Table 68. Pfizer Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Novartis AG Company Details
Table 71. Novartis AG Business Overview
Table 72. Novartis AG Neuropathic Pain Therapeutics Product
Table 73. Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Novartis AG Recent Developments
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Neuropathic Pain Therapeutics Product
Table 78. AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 79. AstraZeneca Recent Developments
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Neuropathic Pain Therapeutics Product
Table 83. GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 84. GlaxoSmithKline Recent Developments
Table 85. Eli Lilly and Company Company Details
Table 86. Eli Lilly and Company Business Overview
Table 87. Eli Lilly and Company Neuropathic Pain Therapeutics Product
Table 88. Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Eli Lilly and Company Recent Developments
Table 90. Mallinckrodt Pharmaceuticals Company Details
Table 91. Mallinckrodt Pharmaceuticals Business Overview
Table 92. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product
Table 93. Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Mallinckrodt Pharmaceuticals Recent Developments
Table 95. Johnson & Johnson Company Details
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson Neuropathic Pain Therapeutics Product
Table 98. Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Johnson & Johnson Recent Developments
Table 100. Abbott Company Details
Table 101. Abbott Business Overview
Table 102. Abbott Neuropathic Pain Therapeutics Product
Table 103. Abbott Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Abbott Recent Developments
Table 105. Endo Pharmaceuticals, Inc. Company Details
Table 106. Endo Pharmaceuticals, Inc. Business Overview
Table 107. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product
Table 108. Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 109. Endo Pharmaceuticals, Inc. Recent Developments
Table 110. Teva Pharmaceutical Industries Limited Company Details
Table 111. Teva Pharmaceutical Industries Limited Business Overview
Table 112. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product
Table 113. Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 114. Teva Pharmaceutical Industries Limited Recent Developments
Table 115. Merck & Co Company Details
Table 116. Merck & Co Business Overview
Table 117. Merck & Co Neuropathic Pain Therapeutics Product
Table 118. Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2017-2022) & (US$ Million)
Table 119. Merck & Co Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathic Pain Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Anticonvulsants Features
Figure 3. Antidepressants Features
Figure 4. NSAIDs Features
Figure 5. Opioids Features
Figure 6. Steroids Features
Figure 7. Others Features
Figure 8. Global Neuropathic Pain Therapeutics Market Share by Application: 2021 VS 2028
Figure 9. Diabetic Neuropathy Case Studies
Figure 10. Chemotherapy-Induced Neuropathy Pain Case Studies
Figure 11. Postherpetic Neuralgia Case Studies
Figure 12. Spinal Cord Injury Case Studies
Figure 13. Others Case Studies
Figure 14. Neuropathic Pain Therapeutics Report Years Considered
Figure 15. Global Neuropathic Pain Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Neuropathic Pain Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Neuropathic Pain Therapeutics Market Share by Region: 2021 VS 2028
Figure 18. Global Neuropathic Pain Therapeutics Market Share by Players in 2021
Figure 19. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Therapeutics as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Neuropathic Pain Therapeutics Revenue in 2021
Figure 21. North America Neuropathic Pain Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Neuropathic Pain Therapeutics Market Size Market Share by Type (2017-2028)
Figure 23. North America Neuropathic Pain Therapeutics Market Size Market Share by Application (2017-2028)
Figure 24. North America Neuropathic Pain Therapeutics Market Size Share by Country (2017-2028)
Figure 25. United States Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Neuropathic Pain Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Neuropathic Pain Therapeutics Market Size Market Share by Type (2017-2028)
Figure 29. Europe Neuropathic Pain Therapeutics Market Size Market Share by Application (2017-2028)
Figure 30. Europe Neuropathic Pain Therapeutics Market Size Share by Country (2017-2028)
Figure 31. Germany Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Neuropathic Pain Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Neuropathic Pain Therapeutics Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Neuropathic Pain Therapeutics Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Neuropathic Pain Therapeutics Market Size Share by Region (2017-2028)
Figure 41. China Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Neuropathic Pain Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Neuropathic Pain Therapeutics Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Neuropathic Pain Therapeutics Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Neuropathic Pain Therapeutics Market Size Share by Country (2017-2028)
Figure 51. Mexico Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Neuropathic Pain Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Neuropathic Pain Therapeutics Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Neuropathic Pain Therapeutics Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Neuropathic Pain Therapeutics Market Size Share by Country (2017-2028)
Figure 57. Turkey Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Neuropathic Pain Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 61. Novartis AG Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 65. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 66. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 67. Abbott Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 68. Endo Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 69. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 70. Merck & Co Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Industry Market Size
